Search research articles
Contact Us
Filters
Showing results (121-130 of 172) with videos related to
Page
of 18
Sort By:
Annals of the Rheumatic Diseases
|
March 11, 2016
The changing landscape of biosimilars in rheumatology
Thomas Dörner, Vibeke Strand, Paul Cornes, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 8, 2018
The Science Behind Biosimilars: Entering a New Era of Biologic Therapy
S Louis Bridges, Douglas W White, Angus B Worthing, et al.
British Journal of Clinical Pharmacology
|
April 6, 2021
Randomised, phase I pharmacokinetic study of adalimumab biosimilar CT-P17 (40 mg/0.4 mL) by autoinjector and prefilled syringe in healthy subjects
Antonia Davidson, Darin Brimhall, Jonathan Kay, et al.
Rheumatology (Oxford, England)
|
December 11, 2012
Systemic sclerosis without antinuclear antibodies or Raynaud's phenomenon: a multicentre study in the prospective EULAR Scleroderma Trials and Research (EUSTAR) database
Daniel Schneeberger, Alan Tyndall, Jonathan Kay, et al.
NPJ Science of Learning
|
May 10, 2025
A new education agenda based on The International Science and Evidence Based Education Assessment
Nandini Chatterjee Singh, Tal Gilead, Anya Chakraborty, et al.
Annals of the Rheumatic Diseases
|
February 20, 2014
Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN)
Joachim Sieper, Jürgen Braun, Jonathan Kay, et al.
Echo Research and Practice
|
November 5, 2017
Transthoracic echocardiography is adequate for intraprocedural guidance of transcatheter aortic valve implantation
Renuka Jain, Daniel P O'Hair, Tanvir K Bajwa, et al.
American Journal of Clinical Dermatology
|
August 7, 2022
Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial
Alan Menter, Stanley Cohen, Jonathan Kay, et al.
Arthritis Care & Research
|
May 22, 2018
Patient Concerns and Perceptions Regarding Biologic Therapies in Ankylosing Spondylitis: Insights From a Large-Scale Survey of Social Media Platforms
Eldin Dzubur, Carine Khalil, Christopher V Almario, et al.
Arthritis Research & Therapy
|
January 29, 2015
Golimumab in patients with active rheumatoid arthritis after treatment with tumor necrosis factor α inhibitors: findings with up to five years of treatment in the multicenter, randomized, double-blind, placebo-controlled, phase 3 GO-AFTER study
Josef S Smolen, Jonathan Kay, Mittie Doyle, et al.
Page
of 18
Search research articles
Search
Showing results (121-130 of 172) with videos related to
Sort By:
Page
of 18
Annals of the Rheumatic Diseases
|
March 11, 2016
The changing landscape of biosimilars in rheumatology
Thomas Dörner, Vibeke Strand, Paul Cornes, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 8, 2018
The Science Behind Biosimilars: Entering a New Era of Biologic Therapy
S Louis Bridges, Douglas W White, Angus B Worthing, et al.
British Journal of Clinical Pharmacology
|
April 6, 2021
Randomised, phase I pharmacokinetic study of adalimumab biosimilar CT-P17 (40 mg/0.4 mL) by autoinjector and prefilled syringe in healthy subjects
Antonia Davidson, Darin Brimhall, Jonathan Kay, et al.
Rheumatology (Oxford, England)
|
December 11, 2012
Systemic sclerosis without antinuclear antibodies or Raynaud's phenomenon: a multicentre study in the prospective EULAR Scleroderma Trials and Research (EUSTAR) database
Daniel Schneeberger, Alan Tyndall, Jonathan Kay, et al.
NPJ Science of Learning
|
May 10, 2025
A new education agenda based on The International Science and Evidence Based Education Assessment
Nandini Chatterjee Singh, Tal Gilead, Anya Chakraborty, et al.
Annals of the Rheumatic Diseases
|
February 20, 2014
Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN)
Joachim Sieper, Jürgen Braun, Jonathan Kay, et al.
Echo Research and Practice
|
November 5, 2017
Transthoracic echocardiography is adequate for intraprocedural guidance of transcatheter aortic valve implantation
Renuka Jain, Daniel P O'Hair, Tanvir K Bajwa, et al.
American Journal of Clinical Dermatology
|
August 7, 2022
Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial
Alan Menter, Stanley Cohen, Jonathan Kay, et al.
Arthritis Care & Research
|
May 22, 2018
Patient Concerns and Perceptions Regarding Biologic Therapies in Ankylosing Spondylitis: Insights From a Large-Scale Survey of Social Media Platforms
Eldin Dzubur, Carine Khalil, Christopher V Almario, et al.
Arthritis Research & Therapy
|
January 29, 2015
Golimumab in patients with active rheumatoid arthritis after treatment with tumor necrosis factor α inhibitors: findings with up to five years of treatment in the multicenter, randomized, double-blind, placebo-controlled, phase 3 GO-AFTER study
Josef S Smolen, Jonathan Kay, Mittie Doyle, et al.
Page
of 18